Category Archives: C. diff. prevention

Study Finds COVID-19 Cleaning Protocols Decreased C. diff. Infections In 2020 Compared To the Past Three Years

 

Protocols enacted by hospital environmental services (EVS) staff and healthcare workers to prevent the spread of the SARS-CoV-2 virus have also been effective against another infectious disease—Clostridium. difficile (C. diff).

 

study in the American Journal of Infection Control found that the incidence of C. diff substantially decreased in 2020 compared to the previous three years due to steps taken to reduce COVID-19 infection, specifically greater attention to hand hygiene, the use of masks, and the proper donning and doffing of personal protective equipment (PPE).

Researchers with Sant’Andrea University Hospital of Rome in Italy compared data on people discharged from the hospital from March 1 to June 30, 2020, to discharge data from 2017, 2018, and 2019. While the investigators found that there was no statistically significant difference in   C. diff incidence in 2017, 2018, and 2019, the 2020 results proved to be quite different.

In 2017, among 422 discharged patients, 39 were found to have C. diff. In 2018, 25 patients from 348 discharged had C. diff and in 2019, 24 patients from 364 discharged had C. diff.

In comparison, only 11 patients among 333 discharged from wards without COVID-19 patients in 2020 had C. diff and seven patients from 150 patients discharged from COVID-19 wards had C. diff.

Investigators could not determine which of the pandemic protocols played the biggest role in slowing C. diff spread, but they noted that previous studies have shown that hand hygiene alone wasn’t enough.

Interestingly, COVID-19 wards showed a higher incidence of C. diff, which suggests coronavirus infection as a possible risk factor for C. diff.

C. diff is the most common pathogen among healthcare-acquired infections (HAIs). Learn cleaning best practices to prevent HAIs in health care facilities.

Who Are Infection Preventionists and Learn Why These Healthcare Professionals Are So Important

October 18th – 24th We Celebrate Infection Preventionists Worldwide.

Who Are Infection Preventionists?

Infection Preventionists (IPs) keep patients and healthcare workers safe from healthcare-associated infections (HAIs).

Take a minute to view the following video to help understand how IPs help improve patient care and safety, especially during the COVID-19 pandemic.

THANK YOU IP’S ~ We Salute Your Efforts And Dedication!

 

Infection Preventionists Save Lives

 

For Additional Information please visit the APIC website

www.apic.org

Researchers Evaluate Healthcare-Onset and Healthcare-Facility-Associated C. difficile Infections

 

Authors:
Dipesh Solanky12Derek K Juang#12Scott T Johns#3Ian C Drobish12Sanjay R Mehta124Monika Kumaraswamy1245

Abstract

Objective: Lack of judicious testing can result in the incorrect diagnosis of Clostridioides difficile infection (CDI), unnecessary CDI treatment, increased costs, and falsely augmented hospital-acquired infection (HAI) rates. We evaluated facility-wide interventions used at the VA San Diego Healthcare System (VASDHS) to reduce healthcare-onset, healthcare-facility-associated CDI (HO-HCFA CDI), including the use of diagnostic stewardship with test ordering criteria.

Design: We conducted a retrospective study to assess the effectiveness of measures implemented to reduce the rate of HO-HCFA CDI at the VASDHS from fiscal year (FY)2015 to FY2018.

Interventions: Measures executed in a stepwise fashion included a hand hygiene initiative, prompt isolation of CDI patients, enhanced terminal room cleaning, reduction of fluoroquinolone and proton-pump inhibitor use, laboratory rejection of solid stool samples, and lastly diagnostic stewardship with C. difficile toxin B gene nucleic acid amplification testing (NAAT) criteria instituted in FY2018.

Results: From FY2015 to FY2018, 127 cases of HO-HCFA CDI were identified. All rate-reducing initiatives resulted in decreased HO-HCFA cases (from 44 to 13; P ≤ .05). However, the number of HO-HCFA cases (34 to 13; P ≤ .05), potential false-positive testing associated with colonization and laxative use (from 11 to 4), hospital days (from 596 to 332), CDI-related hospitalization costs (from $2,780,681 to $1,534,190) and treatment cost (from $7,158 vs $1,476) decreased substantially following the introduction of diagnostic stewardship with test criteria from FY2017 to FY2018.

Conclusions: Initiatives to decrease the risk for CDI and diagnostic stewardship of C. difficile stool NAAT significantly reduced HO-HCFA CDI rates, detection of potential false-positives associated with laxative use, and lowered healthcare costs. Diagnostic stewardship itself had the most dramatic impact on outcomes observed and served as an effective tool in reducing HO-HCFA CDI rates.

 

 

 

 

To view the article in its entirety please click on the link below to be redirected. Thank You.

https://pubmed.ncbi.nlm.nih.gov/32943129/

Researchers Combined Efforts Will Hopefully Lead To Improved Recognition Of Clostridioides difficile Pathogen To Reduce the Suffering and Economic Losses Caused by a CDI

Clostridioides difficile Infection: The Challenge, Tests, and Guidelines

 

Abstract

Clostridioides difficile is a dangerous human pathogen because it can grow to high numbers in the intestine, cause colitis with its potent toxins, and persist as spores. C. difficile infection (CDI) is the primary hospital-acquired infection in North America and Europe, and it now is a global disease. Even with newer laboratory tests, there still is confusion on accurately diagnosing this disease. Three guidelines from three different healthcare-affiliated societies have recently been published. Consensus consolidated recommendations from these guidelines should be recognized by healthcare professionals, who need to understand why this disease continues to be difficult to diagnose and need a clear understanding of the advantages and limitations of current tests. Hopefully, these combined efforts will lead to an improvement in the recognition of this pathogen and a reduction in the suffering and economic loss caused by CDI.

 

 

 

To review the publication in its entirety please click on the link below to be redirected:

https://pubmed.ncbi.nlm.nih.gov/32960044/

The 4th Annual Global C. diff. Awareness 2K Walks Go Virtual on September 11 and 12

The 4th Annual Global C.diff. Awareness 2K Walks Will Now Be VIRTUAL!

                   Join Us On……………….

Friday, September 11th – UK

Dr. Clokie, UK Walk Event Coordinator, will be hosting the VIRTUAL Walk in Leicester on September 11th as the UK is also under strict guidelines to slow the spread of the COVID-19 virus. 

  • The Leicester VIRTUAL Walk Will Begin at 10:00 a.m. – 11:00 a.m. – UK

  • VIRTUAL Entertainment Will Begin at 10:00 a.m. UK For the Children!

Saturday, September 12th –  USA

  • The VIRTUAL Walks Will Begin at 9:00 a.m. through 12:00 p.m. EDT

  • VIRTUAL Entertainment Will Begin at 9:00 a.m. EDT For the Children!

All Registered Awareness Walkers Will Receive a T-Shirt, Giveaways, and More via: United States Postal Service To the Address Provided at the Time Of Registration.

To Learn More About the Global C. diff. Awareness Walk Event and How You Can Register, Please Click On the Green Button Below……………..

 

 

 

We are truly grateful for your efforts, support and participation
of the Annual Walk events and we look forward to virtually walking with you in September!

“None of us can do this alone ~ All of us can do this together!”
~ C Diff Foundation